Shake Shack opened 27 new restaurants in Q2 2026 as system-wide sales rose 13.8% to $625.8 million, while the company invested $104.9 million in property and equipment in the first half as it continued to accelerate expansion of its restaurant footprint.
Delek US Holdings’ refining adjusted EBITDA surged nearly fivefold to $566.2 million in Q2 2026 from $114.8 million a year earlier as substantially stronger refining margins and a 136% increase in benchmark crack spreads transformed the economics of its downstream operations.
Vanda Pharmaceuticals is preparing to commercially launch BYSANTI during the second half of 2026 following FDA approval for bipolar I disorder and schizophrenia, with the therapy protected by data exclusivity into 2031 and patents extending as far as May 2044.
Energy Recovery has opened a new manufacturing facility in Saudi Arabia that will ultimately produce its full line of pressure exchangers, with the company targeting full-scale operations during the first half of 2028 as it moves production closer to one of the world’s largest desalination markets.
Expedia Group raised its 2026 revenue outlook to as much as $16.22 billion after Q2 revenue increased 14% year-over-year to $4.315 billion, with strong B2B growth, margin expansion and higher cash generation allowing management to lift several components of its full-year forecast.
Global Payments generated a 42% normalized adjusted operating margin in Q2 2026, up 70 basis points year over year, in its first full quarter operating as a pure-play commerce solutions provider following the Worldpay acquisition and the disposition of its Issuer Solutions business.
NuScale Power's exclusive global strategic partner ENTRA1 Energy is continuing discussions with the Tennessee Valley Authority toward a definitive power purchase agreement for what NuScale says could become the largest nuclear power deployment program in U.S. history.
Lucid Diagnostics secured its first laboratory benefit manager coverage policy for EsoGuard during Q2 2026, giving the esophageal precancer diagnostic a pathway to coverage across multiple commercial health plans as the company continues to await a potential Medicare coverage decision.
Amplifica Holdings Group has raised $26 million in an oversubscribed Series B financing to advance a pipeline of injectable treatments designed to reactivate dormant hair follicles and stimulate new hair growth. Tasso Partners led the round, with participation from Eli Lilly and Company, principals of Scopia Capital Management, and other new and existing investors.
Citizens Capital Markets & Advisory has added Doug Brockway as a managing director in its Technology Investment Banking group, strengthening the firm's coverage of cybersecurity and infrastructure software. Brockway will lead Citizens' Cybersecurity and Infrastructure Software practice and will be based in Boston.
Vals AI raised a $40 million Series A at a $400 million valuation as the company scales an independent AI evaluation platform that measures how well frontier models perform on real-world professional tasks. Andreessen Horowitz (a16z) led the round, with participation from existing investors 8VC and Bloomberg Beta and new investors HRT Ventures and Next Ladder Ventures.
Unwell, the media and entertainment company co-founded by "Call Her Daddy" host Alex Cooper and producer Matt Kaplan, has raised its first outside funding at a $500 million pre-money valuation as it looks to expand through acquisitions, investments and new business lines, according to Bloomberg.
1789 Capital has closed its inaugural Real Estate Development Fund with $1.2 billion in assets under management, giving the investment firm a sizable pool of capital to pursue more than $8 billion of projected real estate development across fast-growing U.S. markets.
Jasper Therapeutics has completed its acquisition of Kira Pharmaceuticals, creating a combined clinical-stage immunology company with three major development programs and access to resources in both the United States and China, while a concurrent $132 million financing is expected to fund planned operations through the second half of 2028.
Canton Strategic Holdings could increase its active Super Validator weight as much as 30-fold through the first quarter of 2028 as the company scales its role within the Canton Network and begins generating meaningful operating revenue from a new Canton Coin locking service.
Lantern Pharma says its artificial intelligence-driven drug development model has enabled the company to advance new oncology programs from initial AI-derived insights to first-in-human clinical trials for approximately $2 million to $3 million per program, substantially below what management describes as typical industry development costs.
LanzaTech reduced second-quarter operating expenses by 67% year over year as an extensive cost-reduction and organizational restructuring program helped the carbon management company narrow its adjusted EBITDA loss by about 74%.
Rein Therapeutics has surpassed 25% enrollment in its global Phase 2 RENEW trial of LTI-03 for idiopathic pulmonary fibrosis, with enrollment running ahead of schedule and interim clinical data still expected during the second half of 2026 as the company simultaneously reduces R&D and administrative spending.
StablecoinX's cross-chain infrastructure has surpassed $3 billion in cumulative verified volume as the newly public stablecoin infrastructure company builds operating businesses around an ENA treasury representing approximately 20% of the token’s total supply.
Teamshares' trailing-12-month pro forma revenue reached approximately $560 million at the end of the second quarter of 2026 as the newly public company continues building a diversified portfolio of small and midsized businesses through its programmatic acquisition strategy.
Sigma Lithium plans to increase installed lithium oxide concentrate capacity to approximately 830,000 tons annually by the end of 2028, as record second-quarter profitability, lower production costs, and improving operating productivity support a multi-stage expansion of its Brazilian operations.
Suncrete maintained its fiscal 2026 revenue outlook of $420 million to $480 million as strong construction demand across the U.S. Sunbelt and contributions from recent acquisitions helped offset unusually wet weather during the second quarter.
Replimune completed a $150 million financing as the biotechnology company prepares to commercially launch TUDRIQEV following FDA accelerated approval and continues the Phase 3 confirmatory trial required to support the treatment’s longer-term regulatory position.
Americas Gold and Silver plans approximately $45 million to $60 million of combined growth and exploration capital during 2026 as the company increases production capacity at its Galena Complex and conducts what management describes as the largest drilling campaign in its history.
Sinda says its existing mineral resources and conceptual exploration targets provide visibility to more than 800 million silver-equivalent ounces at its project in Mexico, even though drilling has covered only approximately 38% of known veins.
RLX Technology's gross profit rose 47.8% year over year in the second quarter of 2026 as a more favorable revenue mix and supply-chain optimization helped the global e-vapor company expand gross margin by 790 basis points.
Super League's weighted sales pipeline per seller for opportunities through the end of 2026 increased approximately 57% to $2.8 million as the audience intelligence and media activation company expands its commercial organization and integrates new advertising capabilities.
Data Storage Corporation's Nexxis business increased Q2 gross profit by about 22% year over year as revenue from continuing operations rose 9.3%, giving the company a recurring-revenue operating base as it pursues a broader technology acquisition strategy.
VerifyMe's gross margin rose 1,900 basis points to 54% in the second quarter of 2026, even as revenue fell 58%, reflecting shifting economics in the company’s logistics business as it transitions customers to a new strategic shipping partner and expands higher-value Premium services.
Upland Software generated $5.3 million of free cash flow during the second quarter of 2026, nearly double the $2.7 million generated a year earlier, even as reported revenue declined following a series of business divestitures completed in 2025.
Pulse 2.0 NewsletterDaily business and finance intelligence.
Subscribe to the Pulse 2.0 Newsletter
Stay informed with the day's intelligence on business, finance, capital markets, deal flow, law, tech, and AI delivered to your inbox each evening at 6pm ET.